Vizzutti, Francesco <br/><br/>
Curcumin limits the fibrogenic evolution of experimental steatohepatitis.  [electronic resource] 

 -  Laboratory investigation; a journal of technical methods and pathology  Jan 2010 
 - 104-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-0307 
<br/><br/><label>Standard No.: </label>10.1038/labinvest.2009.112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--antagonists & inhibitors<br/>Alanine Transaminase--antagonists & inhibitors<br/>Animals<br/>CD11b Antigen--drug effects<br/>Cells, Cultured<br/>Chemokine CCL2--antagonists & inhibitors<br/>Choline--administration & dosage<br/>Choline Deficiency<br/>Collagen Type I--antagonists & inhibitors<br/>Curcumin--pharmacology<br/>Diet<br/>Enzyme Inhibitors--pharmacology<br/>Fatty Liver--complications<br/>Hepatic Stellate Cells--metabolism<br/>Humans<br/>Liver--metabolism<br/>Liver Cirrhosis--etiology<br/>Male<br/>Methionine--administration & dosage<br/>Mice<br/>Mice, Inbred C57BL<br/>Muscle, Smooth--metabolism<br/>Oxidative Stress--drug effects<br/>Reactive Oxygen Species--antagonists & inhibitors<br/>Tissue Inhibitor of Metalloproteinase-1--antagonists & inhibitors